Propanc Biopharma, Inc.

PPCB·NASDAQ·$1.74Share Price as of 11/2·$2MMarket Cap as of 11/2

Financials

10-KFY 202609/25/26 10-QQ3 ended 03/31/2605/14/26 10-QQ2 ended 12/31/2502/17/26 10-QQ1 ended 09/30/2511/14/25 10-KFY 202509/29/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report07/14/26 8-KCurrent report02/26/26 8-KCurrent report01/07/26 8-KCurrent report11/10/25

Prospectuses and Registrations

S-1Registration statement (IPO)10/05/26 S-1Registration statement (IPO)07/17/26 S-1Registration statement (IPO)04/10/26 424B3Prospectus03/06/26 S-1/ARegistration statement (amended)02/19/26

Proxies

PRE 14APreliminary proxy03/19/26

Ownership

SC 13G/ABeneficial ownership (amended)11/14/25 SC 13GBeneficial ownership08/19/25 Form 4Insider transaction08/23/23 SC 13GBeneficial ownership09/08/21 Form 3Initial insider ownership08/20/21

Other

DEF 14CDefinitive information statement10/21/26 PRE 14CPRE 14C10/08/26 DEF 14CDefinitive information statement08/21/26 PRE 14CPRE 14C08/05/26 EFFECTRequest for effectiveness07/27/26